ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0949

SLAMF7 Engagement Drives Monocyte Super-Activation in Acute and Chronic Inflammation

Daimon Simmons1, Hung Nguyen2, Emma Gomez-Rivas3, YunJu Jeong4, William Apruzzese5, Edy Kim6 and Michael Brenner7, 1Department of Pathology, Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Brigham and Women's Hospital,, Boston, MA, 3Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 4Division of Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, 5., Boston, 6Brigham and Women’s Hospital, Division of Pulmonary and Critical Care Medicine, Boston, MA, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2020

Keywords: COVID-19, Inflammation, innate immunity, Monocytes/macrophages, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Saturday, November 7, 2020

Session Title: Innate Immunity (0945–0949)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Monocytes orchestrate immune responses that protect against microbes but can also drive pathological inflammation and autoimmune disease. Monocytes are thought to be activated primarily by cytokines or by microbial molecules, but they express a broad array of receptors allowing them to integrate responses from the environment. We hypothesize that monocytes may be activated by a first, or primary signal, and that a second, booster stimulus can then drive a pathological super-activated state. To address this hypothesis, we analyzed high dimensional transcriptomic data for monocytes from diseased human tissue to identify receptors that might serve as super-activators of these cells, and identified SLAMF7, a receptor that regulates leukocyte activation.

Methods: We analyzed bulk RNA-sequencing (RNA-seq) data from Phase I of the Accelerating Medicines Partnership to identify genes upregulated in monocytes from rheumatoid arthritis synovial tissue compared to osteoarthritis synovial tissue. We used flow cytometry to quantify this receptor on monocytes and sorted monocytes with high versus low SLAMF7 expression for RNA-seq. We used an activating antibody or recombinant SLAMF7 protein to stimulate monocytes in vitro and performed ELISA to measured cytokine release and quantitative real-time PCR to quantify gene expression. We also collected RNA-seq data from monocytes after stimulation and identified upregulated genes as the “SLAMF7 Activation Signature.” We than analyzed publicly available single cell RNA-seq data from individuals with RA, Crohn’s disease and COVID-19 lung infection with the “SLAMF7 Activation Signature.”

Results: Through differential gene expression analysis we identified SLAMF7 as a receptor that is profoundly upregulated in monocytes from inflamed synovial tissues (fig 1). We identified an interferon signature in SLAMF7-high monocytes, and additional in vitro stimulation experiments implicated IFN-γ as a key regulator of SLAMF7 expression. Engaging SLAMF7 with an antibody or recombinant protein on monocytes drove profound production of inflammatory cytokines TNF-α, IL-6, and IL-1β, and chemokines CCL3, CXCL1, and CXCL8. We performed transcriptome-wide analysis on these stimulated monocytes to generate a “SLAMF7 Activation Signature”. We observed a striking overlap between our experimental signature and the transcriptional signature identified in infiltrating monocytes from RA synovial tissue, bronchoalveolar lavage cells of patients with COVID-19, as well as from ileal tissue of patients with Crohn’s disease.

Conclusion: SLAMF7 is a receptor that is massively upregulated on monocytes from inflamed tissues. IFN-γ drives monocytes to express high levels of SLAMF7 but does not drive complete monocyte activation on its own. A second booster activation signal through engagement of SLAMF7 then triggers profound super-activation, resulting in monocyte production of high levels of inflammatory effector molecules. We implicate this pathway as a major contributor to pathologic inflammation in human diseases. Therapies targeting different steps in monocyte super-activation could have potential for treating diverse human diseases.

Figure 1. Upregulation of SLAMF7 in inflamed synovial tissues. Differentially expressed genes in synovial monocytes from patients with inflamed RA (n=11) compared to OA (n=10) from AMP Phase 1 bulk RNA-sequencing are shown, with SLAMF7 labeled in red.


Disclosure: D. Simmons, None; H. Nguyen, None; E. Gomez-Rivas, None; Y. Jeong, None; W. Apruzzese, None; E. Kim, None; M. Brenner, None.

To cite this abstract in AMA style:

Simmons D, Nguyen H, Gomez-Rivas E, Jeong Y, Apruzzese W, Kim E, Brenner M. SLAMF7 Engagement Drives Monocyte Super-Activation in Acute and Chronic Inflammation [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/slamf7-engagement-drives-monocyte-super-activation-in-acute-and-chronic-inflammation/. Accessed March 8, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/slamf7-engagement-drives-monocyte-super-activation-in-acute-and-chronic-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.